Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 4.5 EX-4.5
- 5.1 EX-5.1
- 10.9 EX-10.9
- 10.12 EX-10.12
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 10.18 EX-10.18
- 10.19 EX-10.19
- 10.20 EX-10.20
- 23.1 EX-23.1
- 23.2 EX-23.2
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
- 99.5 EX-99.5
- 99.6 EX-99.6
- Download Excel data file
- View Excel data file
Associated filings
- 21 May 21 424B3 Prospectus supplement
- 17 May 21 EFFECT Notice of effectiveness
- 17 May 21 424B3 Prospectus supplement
- 13 May 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
5 May 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 26 Mar 21 S-4 Registration of securities issued in business combination transactions
ME similar filings
Filing view
External links
Exhibit 99.2
Consent of Person to be Named as Director
Pursuant to Rule 438 under the Securities Act of 1933, as amended, I hereby consent to being named in the proxy statement/consent solicitation statement/prospectus on Form S-4 of VG Acquisition Corp. (No. 333-254772) (the “proxy statement/consent solicitation statement/prospectus”), as filed with the U.S. Securities and Exchange Commission, as may be amended from time to time, as a nominee to the board of directors of New 23andMe (as defined in the proxy statement/consent solicitation statement/prospectus). I also consent to the filing of this consent as an exhibit to such proxy statement/consent solicitation statement/prospectus and any amendments thereto.
/s/ Evan Lovell | ||
Name: | Evan Lovell | |
Dated: | May 4, 2021 |